Gastric Cancer: Clinical Trials

1,823 trials for Gastric Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

676 completed, 542 unknown, 270 recruiting, 117 terminated. 655 Phase 2, 342 Phase 1, 301 Not applicable, 192 Phase 3, 41 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2655Completed 233, Unknown 189, Recruiting 83, Terminated 62, Active not recruiting 35, Not yet recruiting 32, Withdrawn 14, Suspended 6, Enrolling by invitation 1
Phase 1342Completed 120, Recruiting 59, Unknown 55, Terminated 50, Active not recruiting 34, Withdrawn 14, Not yet recruiting 4, Suspended 4, Enrolling by invitation 2
Not applicable301Unknown 106, Completed 98, Recruiting 55, Not yet recruiting 25, Active not recruiting 8, Terminated 5, Withdrawn 2, Enrolling by invitation 1, Suspended 1
Phase 3192Completed 81, Unknown 52, Recruiting 28, Terminated 13, Not yet recruiting 8, Active not recruiting 7, Withdrawn 3
Phase 441Completed 20, Unknown 11, Not yet recruiting 4, Recruiting 3, Terminated 2, Withdrawn 1
Early Phase 117Unknown 9, Completed 3, Not yet recruiting 2, Terminated 2, Recruiting 1

Follow Gastric Cancer: new trials by email Literature Review of Gastric Cancer trials Research Report on Gastric Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Pembrolizumab and either Capcecitabine + Oxaliplatin or Oxaliplatin+Leucovorin + 5-fluorouracil - Gastric Cancer, Gastroesophageal-junction Cancer
Phase 3Not yet recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.8202027-06-302026-09-29
A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma
ONO-4578, Placebo, Nivolumab - Gastric Cancer, Esophagogastric Junction Cancer
Phase 3Not yet recruitingOno Pharmaceutical Co., Ltd.6002027-02-012026-09-14
Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer
Gastric Cancer
Not yet recruitingLiu Yang3002027-02-012026-07-13
Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Apatinib Mesylate Tablets - Gastric Cancer, Surgery
Phase 3Not yet recruitingFujian Medical University1182026-12-252026-01-02
Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy
Radical Gastrectomy with D2 Lymphadenectomy, Standard Systemic Therapy for Advanced Gastric Cancer - Gastric Cancer, Peritoneal Metastasis
Phase 3RecruitingHua Huang, MD, PhD1702026-12-012026-10-16
Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
Short course radiation therapy, Standard of care neoadjuvant chemotherapy - Gastric Cancer
Phase 2Not yet recruitingWashington University School of Medicine202026-10-312026-08-06
GRACE-DE: Prospective Multicenter Real-world Gastric Cancer Patients Starting AZ-developed and Approved Drugs in Germany (Umbrella Study)
Gastric Cancer, Gastroesophageal Junction Cancer
Not yet recruitingAstraZeneca3002026-10-312026-10-20
Stomach-Partitioning Versus Conventional Gastrojejunostomy for Malignant Gastric Outlet Obstruction: A Multicenter Randomized Controlled Trial
stomach-partitioning gastrojejunostomy, conventional gastrojejunostomy - Gastric Cancer, Gastric Outlet Obstruction
Not applicableNot yet recruitingGuangxi Medical University802026-10-202026-10-15
European Implementation Study on Simultaneous Screening for Gastric and Colorectal Cancers
Fecal sample acquisition for Helicobacter pylori stool antigen test, Upper endoscopy with biopsies, Colonoscopy with biopsies after bowel cleansing - Helicobacter Pylori Infection, Colorectal Cancer
Not yet recruitingUniversity of Latvia80002026-10-012026-10-14
A Phase II Study of Irinotecan Liposome Plus Fruquintinib and Sintilimab in Second-Line PD-L1-Positive Advanced Gastric Cancer
Fruquintinib, Sintilimab, Irinotecan Hydrochloride Liposome Injection (II) - Stomach Neoplasms, Gastric Cancer
Phase 2Not yet recruitingCancer Hospital Chinese Academy of Medical Science, Shenzhen Center202026-10-012026-09-14
A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice
Gastric Cancer, Gastroesophageal Junction Cancer
RecruitingAstraZeneca3002026-09-302026-10-08
Outcomes of Fluoroscopy-Guided Transdiscal Splanchnic Nerve Neurolysis for Upper Abdominal Cancer Pain.
Chemical Neurolysis - Upper Abdominal Cancer Pain, Pancreatic Cancer
Not applicableNot yet recruitingSahiwal medical college sahiwal402026-09-202026-09-17
Evaluation of XYA02 in Patients With Advanced Solid Tumors
XYA02 - MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer
Phase 1 / Phase 2RecruitingXYone Therapeutics, Inc1902026-09-172026-09-25
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
STRO-006, Pembrolizumab - Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer
Phase 1Not yet recruitingSutro Biopharma, Inc.2852026-09-142026-09-08
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
ABBV-253 - Advanced Solid Tumors, Non-Small Cell Lung Cancer
Phase 1RecruitingAbbVie1302026-09-142026-10-16
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Intratumoral 2141-V11, Nivolumab, Fluoropyrimidine - Esophageal Cancer, Advanced Esophageal Cancer
Phase 1 / Phase 2RecruitingMemorial Sloan Kettering Cancer Center302026-09-042026-09-14
NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers
Gastrointestinal Cancer, Gastric Cancer
Not yet recruitingPeking University Cancer Hospital & Institute2002026-09-012026-08-20
Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer
Laparoscopic Gastrectomy, Open Gastrectomy - Gastric Cancer, Gastric Adenocarcinoma
Not yet recruitingKocaeli City Hospital3282026-09-012026-09-03
AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis
Gastric Cancer
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine5422026-09-012026-08-24
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
Neoadjuvant chemotherapy, Olanzapine - Gastric Adenocarcinoma, Gastric Cancer
Phase 2Not yet recruitingUniversity of Illinois at Chicago262026-09-012026-08-21

Showing 20 of 1823. Sign in to see all of them.

Narrower conditions

Stomach Neoplasms (1823)  ·  Esophageal Neoplasms (311)  ·  Pancreatic Neoplasms (212)  ·  Colorectal Neoplasms (204)  ·  Breast Neoplasms (131)  ·  Ovarian Neoplasms (114)  ·  Carcinoma, Non-Small-Cell Lung (112)  ·  Lung Neoplasms (90)  ·  Colonic Neoplasms (89)  ·  Neoplasms (82)  ·  Liver Neoplasms (78)  ·  Carcinoma, Hepatocellular (71)  ·  Urinary Bladder Neoplasms (65)  ·  Uterine Cervical Neoplasms (64)  ·  Melanoma (63)

Broader conditions

Stomach Diseases (1823)  ·  Digestive System Diseases (1822)  ·  Neoplasms by Site (1821)  ·  Digestive System Neoplasms (1819)  ·  Gastrointestinal Diseases (1816)  ·  Gastrointestinal Neoplasms (1788)  ·  Neoplasms (1741)  ·  Esophageal Diseases (323)  ·  Head and Neck Neoplasms (309)  ·  Intestinal Diseases (301)  ·  Endocrine System Diseases (284)  ·  Neoplasms by Histologic Type (284)  ·  Intestinal Neoplasms (280)  ·  Endocrine Gland Neoplasms (279)  ·  Colonic Diseases (268)

Interventions

Oxaliplatin (178)  ·  Capecitabine (126)  ·  Cisplatin (111)  ·  Fluorouracil (111)  ·  S 1 (combination) (88)  ·  Docetaxel (86)  ·  Paclitaxel (76)  ·  Leucovorin (74)  ·  Irinotecan (65)  ·  pembrolizumab (64)  ·  Nivolumab (43)  ·  Trastuzumab (41)  ·  apatinib (41)  ·  Drug Therapy (34)  ·  Radiotherapy (29)

Sponsors

Memorial Sloan Kettering Cancer Center (32)  ·  Fudan University (30)  ·  Peking University (30)  ·  Yonsei University (30)  ·  Fujian Medical University (26)  ·  Tianjin Medical University Cancer Institute and Hospital (25)  ·  Hoffmann-La Roche (23)  ·  Sun Yat-sen University (20)  ·  AstraZeneca (19)  ·  Samsung Medical Center (19)  ·  National Cancer Center, Korea (16)  ·  National Cancer Institute (NCI) (15)  ·  National Taiwan University Hospital (15)  ·  National University Hospital, Singapore (15)  ·  RenJi Hospital (15)

Countries

China (632)  ·  United States (426)  ·  South Korea (252)  ·  Japan (108)  ·  Italy (94)  ·  Spain (92)  ·  United Kingdom (92)  ·  Taiwan (86)  ·  Germany (82)  ·  France (78)  ·  Australia (60)  ·  Canada (51)  ·  Belgium (45)  ·  Poland (44)  ·  Singapore (44)

Top investigators

Yelena Janjigian, MD (7)  ·  Il Ju Choi, M.D., Ph.D. (5)  ·  Syma Iqbal, M.D. (5)  ·  Aminah Jatoi, MD (4)  ·  Chen Li, PH D (4)  ·  David H. Ilson, MD, PhD (4)  ·  Han Liang, Master (4)  ·  Jiafu Ji, MD (4)  ·  Lin Shen, MD (4)

Results publications

PMID 35623069, PMID 40341124, PMID 20728210, PMID 35219300, PMID 38308771, PMID 38421211, PMID 40340830, PMID 15273542, PMID 16822992, PMID 17978289, PMID 18948798, PMID 23207683, PMID 23403142, PMID 25939684, PMID 26352529, PMID 27776843, PMID 28716815, PMID 30557792, PMID 30982686, PMID 31513484, PMID 33538338, PMID 34523717, PMID 35692051, PMID 37788341, PMID 37963317, PMID 38140879, PMID 39089261, PMID 41811823, PMID 10022643, PMID 10091726, PMID 10400410, PMID 10811496, PMID 11248153, PMID 11252008, PMID 11261621, PMID 11391635, PMID 11413430, PMID 11511555, PMID 11547741, PMID 11813623, PMID 11822956, PMID 11895791, PMID 12074329, PMID 12196376, PMID 12454110, PMID 12455783, PMID 12680184, PMID 12794247, PMID 12850683, PMID 12885811

NIH funding

2023 (14), 2017 (9), 2018 (7), 2019 (5), U10CA032102 (4), 2016 (3), P30CA016672 (3), P30CA068485 (3), 2009 (2), 2015 (2), P30CA015083 (2), P30CA016087 (2), 2005 (1), 2008 (1), 2014 (1)